Login / Signup

Cognitive impairment in Parkinson's disease is multifactorial: A neuropsychological study.

Callum R SmithBreda CullenMatthew P SheridanJonathan CavanaghKatherine A GrossetDonald G Grosset
Published in: Acta neurologica Scandinavica (2020)
Neuropsychological testing identifies distinct patterns of cognitive impairment in Parkinson's disease that provide clear pointers to comorbid disease processes, the most common being Alzheimer's disease. This approach may prove useful in clinical practice and has implications for clinical trials that target α-synuclein.
Keyphrases
  • cognitive impairment
  • clinical trial
  • clinical practice
  • gene expression
  • dna methylation
  • study protocol
  • double blind